Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL888643 | 0.82 | — | — | |
| SCHEMBL13954120 | 0.79 | ALDH1A1 (0.34) | ALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL23385891 | 0.77 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL13934074 | 0.77 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9249695 | 0.77 | TSHR (0.31) | ALDH1A1 | |
| SCHEMBL10125689 | 0.77 | KDM4E (0.32) | — | |
| SCHEMBL16887591 | 0.75 | SMN1; SMN2 (0.36) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL9253362 | 0.75 | KDM4E (0.34) | ALDH1A1 | |
| SCHEMBL15113942 | 0.73 | — | — | |
| SCHEMBL24421368 | 0.73 | LMNA (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180057505-A1 | BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY | VERTEX PHARMACEUTICALS INCORPORATED | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057505-A1 | BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY | F2RL1, PARP12, TFPI2 | ALDH1A1 3037/4885PKM 807/4885SMN1; SMN2 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.